BioSpace News Archive

Pixium Vision announces that its next-generation miniaturized wireless sub-retinal implant, PRIMA, received authorization from the French regulatory agency, to start a feasibility clinical study in patients with advanced dry age-related macular degeneration (dry-AMD).

Benson Hill Biosystems today announced at the Future Food-Tech Conference the commercial launch of Edit, powered by CropOS, the first complete genome editing system made accessible to partners for the development of improved crops.

Danaher today announced results for the third quarter of 2017.

BioLife Solutions today announced that its customer Kite Pharma has received US FDA approval for Yescarta, the first CAR T-cell therapy for treatment of adult patients with relapsed or refractory large B-Cell lymphoma after two or more lines of systemic therapy.

J&J today announced that its Board of Directors has declared a cash dividend for the fourth quarter of 2017 of $0.84 per share on the company’s common stock.

Dynavax Technologies Corporation announced initiation of dosing in a phase 1B dose escalation clinical trial of its investigational inhaled toll-like receptor 9 (TLR9) agonist, DV281, in patients with non-small cell lung cancer (NSCLC).

Cellect announced today that it has nominated Dr. Ronit Bakimer-Kleiner as Chief Development Officer replacing Dr. Yaron Pereg.

Vitality Biopharma, a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, today announced additional positive preclinical efficacy results for the treatment of colitis.

Kent’s device is the next step in perfusion imaging by directly showing tissue oxygenation.

Thermo Fisher Scientific today announced the commercial launch of the Applied Biosystems Axiom Africa Array for medical and population genomics to accelerate and support initiatives in global health and population research.